The effect of the potassium channel activator, cromakalim, on antidepressant drugs in the forced swimming test in mice

Fundamental and Clinical Pharmacology

Volumn 10, Issue 6, 1996, Pages 524-528

  Redrobe, J P ^a   Pinot, P ^a   Bourin, M ^a  

^a Faculty of Medicine   (France)

Author keywords

Antidepressant; Forced swimming; Potassium channels

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CLONIDINE; CROMAKALIM; DESIPRAMINE; IMIPRAMINE; LITHIUM; MIANSERIN; MINOXIDIL; NEUROTRANSMITTER; PAROXETINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; QUININE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BLOOD BRAIN BARRIER; FORCED SWIMMING TEST; IMMOBILIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029851929     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1996.tb00610.x     Document Type: Article

References (27)

1. Armitage P, Berry G. Statistical Methods in Medical Research, 2nd edn. Oxford: Blackwell, 1987;203-5
2. Bourin M, Colombel MC, Malinge M, Bradwejn J. Clonidine as a sensitizing agent in the forced swimming test for revealing antidepressant activity. J Psychiatr Neurosci 1991;16:199-203
3. Bourin M, Colombel MC, Hascoet M, Nizard J, Baker GB. Evaluation of efficacies of different classes of antidepressants in the forced swimming test in mice at different ages. Eur Neuropsychopharm 1996; in press
4. Bourin M, Hascoet M, Colombel MC, Redrobe JP, Baker GB. Differential effects of clonidine, lithium and quinine in the forced swimming test in mice for antidepressants: possible roles of serotonergic systems. Eur Neuropsychopharm 1996;6:231-6
5. Borsini F, Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology 1988;94:147-60
6. Buckingham RE, Clapham JC, Hamilton TC, Longman SD, Norton J, Poyser RH. BRL 34915, a novel anti-hypertensive agent; comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal models. J Cardiovasc Pharmacol 1986;8:798-802
7. Coldwell MC, Howlett DR. Specificity of action of the novel hypertensive agent, BRL 34915, as a potassium channel activator. Biochem Pharmacol 1987;36:3663-9
8. Cook DL, Hales CN. Intracellular ATP directly block K+ channels in pancreatic beta cells. Nature 1984;311:271-3
9. 2+-dependent 5-hydroxytryptamine release from neurones of the rat brain cortex. Naunyn Schmiedebergs Arch Pharmacol 1980;314:223-230
10. Guo W, Todd K, Bourin M, Hascoet M. The additive effects of quinine on antidepressant drugs in the forced swimming test. Psychopharmacology 1995;121:173-9
11. Guo W, Todd K, Bourin M, Hascoet M, Kouadio F. Additive effects of glyburide and antidepressants in the forced swimming test: further evidence for the involvement of potassium channel blockade. Pharmacol Biochem Behav 1996;54:725-30
12. Hamilton TC, Weir SW, Weston AH. Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein. Br J Pharmacol 1986;88:103-8
13. Henquin JC. D-glucose inhibits potassium efflux from pancreatic islet cells. Nature 1978;271:271-3
14. Keuls M. The use of studentized range in connection with an analysis of variance. Euphytica 1952;1:112-22
15. 4 receptors. Br J Pharmacol 1995;114:1017-25
16. Malinge M, Bourin M, Colombel MC, Larousse C. Additive effects of clonidine and antidepressant drugs in the mouse forced swimming test. Psychopharmacology 1988;96:104-9
17. Mourre C, Widmann C, Lazdunski M. Sulphonylurea binding sites associated with ATP-regulated K+ channels in the central nervous system: autoradiographic analysis of their distribution and ontogenesis, and of their localization in mutant mice cerebellum. Brain Res 1990;519:29-43
18. Nixon MK, Hascoet M, Bourin M, Colombel MC. Additive effects of lithium and antidepressants in the forced swimming test: further evidence for involvement of the serotonergic system. Psychopharmacology 1994;115:59-64
19. Noma A. ATP-regulated K+ channels in cardiac muscle. Nature 1983;305:147-8
20. Porsolt RD, Bertin A, Jalfre M. Behavioural despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977;229:327-36
21. Spruce AH, Standen NB, Stanfield PR. Voltage-dependent ATO-sensitive potassium channels of skeletal muscle membrane. Nature 1985;316:736-8
22. Standen NB, Quayle JM, Davies NW, Brayden JH, Huang Y, Nelson MT. Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. Science 1989;245:177-80
23. Thomas RC, Hsi RSP, Harpootlian H, Judy RW. Metabolism of minoxidil, a new hypertensive agent. I. Absorption, distribution and excretion following administration to rats, dogs and monkeys. J Pharm Sci 1975;65:1360-6
24. Tricklebank MD, Flockhart G, Hreedman SB. The potassium channel activator, BRL 34915, antagonizes a behavioral response to the muscarinic receptor agonist, pilocarpine. Eur J Pharmacol 1988;151:349-50
25. 3 receptor. Brain Res 1990;533:46-52
26. 2-adrenoreceptor mediated effects on norepinephrine release. J Neurosri Res 1988;20:102-8
27. Zunkler BJ, Lenzen S, Manner, K, Panten U, Trube G. Concentration-dependent effects of tolbutamide, meglitinide, glipizide, glibenclamide and diazoxide on ATP-regulated K+ currents in pancreatic beta cells. Nauyn Schmiedebergs Arch Pharmacol 1988;337:225-30